Depression, anxiety prevalence similarly elevated among patients with IBS, ulcerative colitis
Click Here to Manage Email Alerts
ORLANDO, Fla. — Patients with irritable bowel syndrome or ulcerative colitis had similarly increased prevalence of depression and/or anxiety compared with controls in a study presented at Digestive Disease Week.
Researchers performed a systematic review of case-control studies analyzing depression and anxiety among patients with IBS (seven studies; 668 patients and 294 controls) or ulcerative colitis (UC) (three studies; 261 patients and 282 controls). Symptoms of depression or anxiety were measured according to methods including the Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory and the State-Trait Anxiety Index.
Among the IBS studies, six indicated either increased prevalence or higher scores for both depression and anxiety in patients with IBS compared with controls. All UC studies found increased prevalence or score for anxiety among patients, while two also indicated increased depression prevalence or score.
Overall, patients with UC had either similar or greater degrees of psychological abnormalities compared with IBS patients. Depression was observed in 38% of IBS patients, while anxiety was present in 32%, compared with 50% and 64%, respectively, among those with UC. The mean HADS depression score for IBS patients was 5.4, compared with 4.1 among those with UC, while mean HADS anxiety scores were 8.1 and 8.5, respectively.
“Just because patients with depression also happen to have IBS or vice versa, it’s not that one necessarily causes the other,” Eric D. Shah, MD, internal medicine resident at Cedars-Sinai Medical Center in Los Angeles, told Healio.com. “We’ve seen that published in a lot of studies previously, that depression causes IBS, but we used UC as our negative control and saw even more in terms of prevalence, [and IBS] is similar to UC in terms of change to depression and anxiety scores. Based on existing data, we can’t say that depression causes IBS, but it’s still there; ... we still see one-third of patients who have depression [or] anxiety.”
Disclosure: Researcher Mark Pimentel performed consulting services for Salix Pharmaceuticals and received grant/research support from Salix and Seaver Foundation.
For more information:
Shah ED. Sa1339: A Comparison of Psychological Associations with IBS and Ulcerative Colitis. Presented at: Digestive Disease Week 2013; May 18-21, Orlando, Fla.